DNA Methylation and Hydroxymethylation Levels in Patients With Coronary Heart Disease

NCT03462277 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2019-07-17

No results posted yet for this study

Summary

The purpose of this trial is to investigate the relationship between DNA methylation and hydroxymethylation and the expression of DNMTs, TET family gene and the degree of coronary heart disease.

Conditions

Sponsors & Collaborators

  • Chongqing Medical University

    lead OTHER

Principal Investigators

  • Dongying Zhang, doctor · First Affiliated Hospital of Chongqing Medical University

  • Dan Jiang · First Affiliated Hospital of Chongqing Medical University

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2018-08-01
Completion
2018-10-01

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03462277 on ClinicalTrials.gov